Here at Diabetic Investor we follow several different information sources to kept abreast of what’s going on in this wacky world of ours. Towards the end of the year we see lots of lists and one in particular caught our attention. Per a post on the Medical Device and Diagnostic Industry web site;
“The people have spoken. Beta Bionics has been named medtech company of the year. Nearly 44% of MD+DI readers participating in a special poll voted for the Boston, MA-based company, which is developing an artificial intelligence-powered bionic pancreas, called the iLet, to help . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.